伴随性抑郁症和自主功能障碍会降低慢性阻塞性肺病患者的肺功能
1Department of Psychosomatic, Jianyang People's Hospital, Jianyang 641400, Sichuan Province, China. 1015950973@qq.com.
抑郁症显著影响慢性阻塞性肺病 (COPD) 患者. 综合治疗结合药物治疗,治疗和生活方式改变,改善心率变化和肺功能,提高生活质量.
科学领域:
- 肺部医学 肺部医学
- 精神病学是一个精神病学.
- 整合性健康 整合性健康
背景情况:
- 抑郁症和慢性阻塞性肺病 (COPD) 的高并发症率带来了重大的临床挑战.
- 长期的COPD压力会加剧抑郁症,通过生物和心理途径对肺功能产生负面影响.
研究的目的:
- 探索抑郁症和COPD之间的复杂关系.
- 突出仅用于COPD共发性抑郁症的生物医学治疗方法的局限性.
- 倡导综合治疗方法.
主要方法:
- 关于抑郁症和COPD之间相互作用的现有文献的审查.
- 对连接抑郁症与肺功能减弱的生理机制的分析.
- 讨论多模式治疗策略.
主要成果:
- 在COPD患者中,抑郁症与心率变化降低,炎症增加和HPA轴调节失调有关.
- 仅仅通过生物医学治疗,就不足以解决抑郁症对COPD的多方面的影响.
- 包括抗抑郁药,中国传统医学,心理治疗和生活方式调整在内的综合疗法显示出有前途.
结论:
- 综合治疗方法对于治疗COPD患者的并发性抑郁症至关重要.
- 多模式策略可以改善精神健康和呼吸系统的结果.
- 临床医生必须仔细考虑这种人群中抗抑郁药的益处风险比.
更多相关视频
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids
